Clinical Trial Update: A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication [Phase 3]

View source ↗

Summary

A Phase 3 study of Lebrikizumab in uncontrolled asthma on inhaled corticosteroids and a second controller medication has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Asthma | Phase 3 | Status: COMPLETED